QualityStocksNewsBreaks Archives - Page 1252 of 1421

WednesdaySep 05, 2018 10:36 am

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Unveils Brand Forward Strategy for the Cannabis Industry

Cannabis Strategic Ventures (OTC: NUGS) this morning announced its increased commitment to cannabis industry brands and innovators through the development of a proprietary branding and partnership model for the cannabis industry. As its primary investment focus, Cannabis Strategic Ventures intends to continue to develop multiple proprietary brands over the coming months. The company also aims to continue its work to enhance its infrastructure, product sourcing, communication and content support offerings. “Branding is becoming more important to the development of this industry,” Cannabis Strategic Ventures CEO Simon Yu stated in the news release. “As a firm, we predict consumer-focused cannabis brands will…

WednesdaySep 05, 2018 10:01 am

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Announces Additional Investment in StakeHaul

SinglePoint, Inc. (OTCQB: SING) this morning announced its completion of an additional investment in StakeHaul, the premier peer-to-peer betting application. StakeHaul offers a unique way for individuals to bet on anything, from the NFL’s week one matchups to a weekend round of golf. Per the update, StakeHaul has had over 70,000 lifetime downloads and consistent double-digit percentage growth in both monthly active users and bets placed on the platform. The StakeHaul team is currently finalizing testing for a new peer-to-peer payment model for lost bets in both USD and cryptocurrency, which will be a first in the industry. This push…

WednesdaySep 05, 2018 9:57 am

QualityStocksNewsBreaks – Zenosense, Inc. (ZENO) MIDS Medical Ltd. JV Secures Up to $1.2M in Staged Funding

Zenosense (OTC: ZENO), a healthcare technology company, this morning announced that its MIDS Medical Ltd. (“MML") joint venture (“JV”) has entered a staged funding for the next phase of development of the MIDS Cardiac™ hand-held technology. MML entered into an agreement with a third-party investor for funding of up to a total of $1,200,000 on August 31, 2018. The funding is anticipated to cover the expenses of the next key development phase intended to prove that the MIDS magnetic detection method can detect and accurately quantify a live high sensitivity (“HS”) assay on the MIDS microfluidic test strip. Per the…

WednesdaySep 05, 2018 9:17 am

QualityStocksNewsBreaks – Hunter Oil Corp. (TSX.V: HOC) (OTCQX: HOILF) to Pay Return of Capital Distribution to Shareholders of Record

Hunter Oil (TSX.V: HOC) (OTCQX: HOILF) recently announced that it will pay a return of capital distribution of CAD $1.625 (approximately USD $1.25) per common share of the company to all registered shareholders of record at the close of business on September 11, 2018. The distribution represents the proceeds the company received from the sale of its assets, less outstanding liabilities and USD $2,500,000 for working capital. The distribution to unregistered shareholders holding through intermediaries will be made in accordance with the “due bill” trading procedures of the TSX Venture Exchange. The purpose is to have traded shares carry the…

WednesdaySep 05, 2018 9:05 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) to Develop PRO 140 as Therapy for Triple-Negative Breast Cancer

Biotechnology company CytoDyn Inc. (OTCQB: CYDY) this morning detailed its plan to develop PRO 140 (leronlimab) as a therapy for metastatic triple-negative breast cancer. Per the update, previously announced findings from preclinical studies showed the ability of PRO 140 to block human breast cancer cellular invasion in a surrogate assay for metastatic breast cancer. “We plan to aggressively pursue the development of PRO 140 as a therapy for women with metastatic triple-negative breast cancer, which is in keeping with our strategy to evaluate PRO 140 in certain cancers and immunological indications where CCR5 antagonism has shown initial promise,” Nader Pourhassan,…

TuesdaySep 04, 2018 3:20 pm

QualityStocksNewsBreaks – Why CytoDyn Inc. (CYDY) is “One to Watch”

Biotechnology company CytoDyn (OTCQB: CYDY) is focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. A recent article discussing the company reads: “The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are…

TuesdaySep 04, 2018 2:38 pm

QualityStocksNewsBreaks – Accelerated Technologies Holding Corp. (ATHC) Receives Positive Feedback from Intelagy Launch

Accelerated Technologies Holding’s (OTC: ATHC) managing director, Alex Lemberg, recently spoke to NetworkNewsAudio’s Stuart Smith about the company’s launch of Intelagy. ATHC reported a significantly positive response to its new credit card processing solution. An article discussing the company reads: “ATHC, which provides consulting and develops technology products and services, recently launched Intelagy, which provides a range of services, including credit card processing, branding, web development and hosting solutions, to small-to-medium businesses. “Yesterday we did our first fairly decent-sized marketing campaign,” Lemberg said in the interview (http://ibn.fm/XQzgu). … Intelagy is subscription-based, meaning that merchants can choose to pay for the level…

TuesdaySep 04, 2018 2:33 pm

QualityStocksNewsBreaks – Auscrete Corp. (ASCK) Plans to Commence Production at Flagship Facility by Year-end

Auscrete (OTC: ASCK), a building products manufacturer of environmentally-friendly, energy-efficient housing and commercial structures, intends to commence production from its flagship facility in Goldendale, Washington by the end of this year. A recent article discussing the company reads: “ASCK is a building manufacturing company focused on ‘green’, energy efficient structures made from lightweight hybrid concrete/insulation wall and roof panels. The company, which is positioning itself as a major supplier in the affordable housing market, has stated that these units have very low maintenance costs. They are resistant to insects and mold, as well as natural events such as hurricanes and…

TuesdaySep 04, 2018 11:39 am

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Develops Proprietary Cannabinoid Extraction Protocol

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) today announced that it has successfully optimized its extraction protocol during its soluble gel ("Sol-gel") drug delivery research and development program. The company augmented the circumstances for extracting cannabinoids from one of its cannabis strains and established a proprietary method for the accurate quantification of cannabinoids present in the extract. The accuracy and precision of the company’s extraction protocol was confirmed against eight commercial cannabinoid standards over a wide concentration range. PreveCeutical anticipates that the new protocol will accelerate the creation of a library of chemically fingerprinted cannabinoid extracts.…

Site Search

Company Search

Category: QualityStocksNewsBreaks